Ubiquitin-specific protease 14 (USP14) regulates cellular proliferation and apoptosis in epithelial ovarian cancer

Medical Oncology

Volumn 32, Issue 1, 2015, Pages

  Wang, Yingying ^a   Wang, Juan ^a   Zhong, Jianxin ^a   Deng, Yan ^a   Xi, Qinghua ^a   He, Song ^a   Yang, Shuyun ^a   Jiang, Lifei ^a   Huang, Menghui ^a   Tang, Chunhui ^a   Liu, Rong ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Epithelial ovarian cancer; Proliferation; USP14

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; DEUBIQUITINASE; UBIQUITIN SPECIFIC PROTEASE 14; UNCLASSIFIED DRUG; SMALL INTERFERING RNA; TUMOR MARKER; UBIQUITIN THIOLESTERASE; USP14 PROTEIN, HUMAN;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER THERAPY; CELL CYCLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SURVIVAL; CLEAR CELL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ENDOMETRIOID CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PAPILLARY CARCINOMA; REGULATORY MECHANISM; SEROUS PAPILLARY ADENOCARCINOMA; UBIQUITINATION; UNDIFFERENTIATED CARCINOMA; WESTERN BLOTTING; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING; TRANSFECTION; UBIQUITIN THIOLESTERASE; YOUNG ADULT;

EID: 84919883904     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0379-8     Document Type: Article

References (26)

1. Siegel R, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.
2. Anuradha S, et al. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study. Med J Aust. 2014;201(5):283–8.
3. Mialki RK, et al. Overexpression of USP14 protease reduces I-κB protein levels and increases cytokine release in lung epithelial cells. J Biol Chem. 2013;288(22):15437–41.
4. Adams J. Development of the proteasome inhibitor PS-341. Oncologist. 2002;7(1):9–16.
5. Puente XS, et al. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet. 2003;4(7):544–58.
6. Ishiwata S, et al. Increased expression of queuosine synthesizing enzyme, tRNA-guanine transglycosylase, and queuosine levels in tRNA of leukemic cells. J Biochem. 2001;129(1):13–7.
7. Shinji S, et al. Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases. Oncol Rep. 2006;15(3):539–43.
8. Chuensumran U, et al. Ubiquitin-specific protease 14 expression associated with intrahepatic cholangiocarcinoma cell differentiation. Asian Pac J Cancer Prev. 2011;12(3):775–9.
9. Wu N, et al. Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of beta-catenin. Int J Mol Sci. 2013;14(6):10749–60.
10. Wu N, et al. MiR-4782-3p inhibited non-small cell lung cancer growth via USP14. Cell Physiol Biochem. 2014;33(2):457–67.
11. Yang Y, et al. Differential expression of USP2, USP14 and UBE4A between ovarian serous cystadenocarcinoma and adjacent normal tissues. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007;23(6):504–6.
12. Semaan A, et al. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf(1)/cip(1)). Pharm Res. 2011;28(12):3079–90.
13. Hang Q, et al. Expression of Spy1 protein in human non-Hodgkin’s lymphomas is correlated with phosphorylation of p27Kip1 on Thr187 and cell proliferation. Med Oncol. 2012;29(5):3504–14.
14. Kapuria V, et al. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. Cancer Res. 2010;70(22):9265–76.
15. Kim BG, et al. Activation of caspases and inhibition of ribosome biogenesis mediate antitumor activity of Chijongdan in A549 non-small lung cancer cells. BMC Complement Altern Med. 2014;14(1):420.
16. Booher RN, et al. MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosis. PLoS One. 2014;9(10):e108371.
17. CL Walters Haygood, et al. Ovarian cancer stem cells: can targeted therapy lead to improved progression-free survival? World. J Stem Cells. 2014;6(4):441–7.
18. Tian Z, et al. A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance. Blood. 2014;123(5):706–16.
19. Weathington NM, Mallampalli RK. Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Invest. 2014;124(1):6–12.
20. Ding F, et al. The role of the ubiquitin–proteasome pathway in cancer development and treatment. Front Biosci (Landmark Ed). 2014;19:886–95.
21. Chen D, Dou QP. The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention. Curr Protein Pept Sci. 2010;11(6):459–70.
22. Romano A, Conticello C, Di Raimondo F. Bortezomib for the treatment of previously untreated multiple myeloma. Immunotherapy. 2013;5(4):327–52.
23. Takagi K, Mizushima T. Structure and functional mechanisms of proteasome dedicated chaperones. Seikagaku. 2013;85(9):789–94.
24. Ernst A, et al. A strategy for modulation of enzymes in the ubiquitin system. Science. 2013;339(6119):590–5.
25. Musat M, et al. Cell cycle dysregulation in pituitary oncogenesis. Front Horm Res. 2004;32:34–62.
26. Brnjic S, et al. Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress. Antioxid Redox Signal. 2013. doi:10.1089/ars.2013.5322.